156 related articles for article (PubMed ID: 38809918)
1. TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF-κB signalling pathway.
Wang S; Sun Y; Li C; Chong Y; Ai M; Wang Y; Shi H; Shang Y
J Cell Mol Med; 2024 May; 28(10):e18391. PubMed ID: 38809918
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
3. EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer.
Li Y; Liu J; Xiao Q; Tian R; Zhou Z; Gan Y; Li Y; Shu G; Yin G
Cell Death Dis; 2020 Jul; 11(7):604. PubMed ID: 32732864
[TBL] [Abstract][Full Text] [Related]
4. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183.
Shen T; Cheng X; Liu X; Xia C; Zhang H; Pan D; Zhang X; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4038-4045. PubMed ID: 31608699
[No Abstract] [Full Text] [Related]
5. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
[TBL] [Abstract][Full Text] [Related]
6. The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20.
Yu X; Yuan Z; Yang Z; Chen D; Kim T; Cui Y; Luo Q; Liu Z; Yang Z; Fan X; Chen D; Wang L
Cell Death Dis; 2018 Jul; 9(7):751. PubMed ID: 29970882
[TBL] [Abstract][Full Text] [Related]
7. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
Ma ZH; Shi PD; Wan BS
Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196
[TBL] [Abstract][Full Text] [Related]
8. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
[TBL] [Abstract][Full Text] [Related]
9. RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer.
Ouyang J; Hu S; Zhu Q; Li C; Kang T; Xie W; Wang Y; Li Y; Lu Y; Qi J; Xia M; Chen J; Yang Y; Sun Y; Gao T; Ye L; Liang Q; Pan Y; Zhu C
Cell Death Dis; 2024 Jun; 15(6):437. PubMed ID: 38902257
[TBL] [Abstract][Full Text] [Related]
10. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
11.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
12. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
13. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
Liang ZX; Liu HS; Xiong L; Yang X; Wang FW; Zeng ZW; He XW; Wu XR; Lan P
Mol Cancer; 2021 Aug; 20(1):103. PubMed ID: 34412652
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway.
Yan K; Xu X; Wu T; Li J; Cao G; Li Y; Ji Z
Biochem Biophys Res Commun; 2019 Dec; 520(2):486-491. PubMed ID: 31606203
[TBL] [Abstract][Full Text] [Related]
15. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
[TBL] [Abstract][Full Text] [Related]
17. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
[TBL] [Abstract][Full Text] [Related]
18. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation.
Vicinus B; Rubie C; Stegmaier N; Frick VO; Kölsch K; Kauffels A; Ghadjar P; Wagner M; Glanemann M
Oncol Rep; 2013 Sep; 30(3):1285-92. PubMed ID: 23817679
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
20. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis.
Geng R; Tan X; Wu J; Pan Z; Yi M; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Cell Death Dis; 2017 Aug; 8(8):e2994. PubMed ID: 28796265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
